NCT06688318View on ClinicalTrials.gov

Effectivity of Allogenic Umbilical Cord Mesenchymal Stem Cells Conditioned Media for Osteoarthritis of the Knee Joint

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2024

Conditions
Osteoarthritis Knee
Interventions
BIOLOGICAL

Intra-articular secretome injection therapy

Intra-articular secretome injection therapy from hypoxic umbilical cord mesenchymal stem cell conditioned media

Trial Locations (1)

57126

Moewardi General Hospital, Surakarta

All Listed Sponsors
lead

Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia

OTHER_GOV